Alector, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ALEC Nasdaq 2836 www.alector.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alector, Inc.

Alector: Q3 Earnings Snapshot - Nov 5th, 2026 4:58 pm
Alector Reports Third Quarter 2026 Financial Results and Provides Business Update - Nov 5th, 2026 2:05 pm
What Alector Shareholders Got Right - Nov 2nd, 2026 10:10 pm
Earnings Preview: Moderna (MRNA) Q3 Earnings Expected to Decline - Oct 30th, 2026 7:00 am
Will Alector (ALEC) Report Negative Q3 Earnings? What You Should Know - Oct 29th, 2026 7:00 am
Alector stock surges 13% on premium-priced equity offering - Oct 16th, 2026 7:26 am
Alector Announces Pricing of Underwritten Offering - Oct 16th, 2026 5:30 am
Alector (ALEC) Stock Fair Value Rises After Genentech Deal Draws Split Analyst Views - Oct 15th, 2026 6:21 pm
Alector Maps Brain-Delivery Pipeline for Alzheimer’s, Parkinson’s Therapies - Oct 13th, 2026 1:02 pm
Stocktwits Biotech Dealmaker — Viatris And GE Healthcare Buy What They Can Sell; Biohaven And Alector Sell Rights - Oct 9th, 2026 7:12 pm
Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline - Oct 7th, 2026 2:05 pm
Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal - Oct 6th, 2026 4:59 am
BC-Most Active Stocks - Oct 5th, 2026 8:30 am
Alector Signs $1.27 Billion Genentech License Agreement for Parkinson’s Disease Program - Oct 5th, 2026 8:13 am
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug - Oct 5th, 2026 7:57 am
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases - Oct 5th, 2026 5:00 am
Alector to Participate in Upcoming Healthcare Conferences - Sep 3rd, 2026 2:05 pm